Evaluation of immune response to hepatitis A vaccination and vaccine safety in juvenile idiopathic arthritis

Abstract

Hepatitis A vaccine was safe in patients with JIA, and response to vaccine did not differ between healthy children and patients with JIA except for children with active systemic JIA receiving anti-tumor necrosis factor alpha drugs.